Peter McDonald

Peter McDonald has a strong background in the healthcare and biotechnology sectors. Peter worked for Stemline Therapeutics, Inc. from 2014 to 2018, holding positions as Sr. VP, Corporate and Business Development, and VP Business Development and Investor Relations. Prior to that, they were a Senior Equity Analyst at Auriga USA, LLC from 2010 to 2012, where they provided investment opinions on various life science tools, diagnostic, and biotechnology companies. From 2007 to 2009, McDonald worked as a Research Analyst at Wall Street Access, focusing on healthcare. Peter was also a Vice President at American Technology Research from 2006 to 2007, where they provided investment opinions and hosted investor events in the life science tools and biotechnology sectors.

Peter McDonald obtained a Bachelor of Science degree in Chemistry from SUNY Geneseo, where they studied from 1991 to 1995. Peter later pursued an MBA degree at Fordham Gabelli School of Business from 1997 to 1999.